Skip to main content
search

Press Coverage

Sign up

Popular coverage

All coverage

Digital twins and virtual trials: A new era in rare disease drug development

Modeling and Simulation - QSP, Rare and Neglected Diseases, Therapeutic Specialties, Press Coverage

End of Animal Testing? Advancing Drug Development Alternatives

Certara Products - Simcyp, Homepage Latest, Modeling and Simulation, Press Coverage

Streamline Your Regulatory Writing with Process Infographics

Certara Services, Press Coverage

The Medicine Maker: The Biosimulation Generation

Certara Services, Clinical Trials, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation – PK/PD, Modeling and Simulation – QSP, Press Coverage

Increasing Productivity In Pharma R&D Starts With Data

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Homepage Latest, Press Coverage

How is the pharmaceutical industry addressing global health inequities?

Certara Products - Simcyp, Certara Services, Modeling and Simulation - PBPK, Press Coverage

What’s next for Trump’s ‘most favored nation’ policy?

Certara Services, Press Coverage

Rare disease drug development: challenges, support and hopes for the future

Certara Services, Press Coverage

FDA to phase out animal testing with AI and lab-based models

Certara Products - Simcyp, Certara Services, Press Coverage

FDA plans to phase out animal testing requirements

Biologics, Certara Services, Drug Development, Model Informed Drug Development, Press Coverage

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Press Coverage

How biosimulation and virtual trials can bust through clinical trial roadblocks

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Press Coverage
Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.